Primary health sources
NIDDK: Enlarged Prostate (Benign Prostatic Hyperplasia); Prostate Problems. Used for symptom and medical-red-flag context.
NCCIH: Saw Palmetto: Usefulness and Safety; Benign Prostatic Hyperplasia and Complementary and Integrative Approaches. Used for evidence summaries on saw palmetto and pygeum.
Cochrane: 2023 review, Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement.
Product information sources
ProstaDefend merchant page: prostakey.com landing page reviewed {CHECKED}. Used for named ingredients, suggested use, guarantee and merchant claims.
1MD Nutrition ProstateMD: current 1MD product and label-information pages reviewed {CHECKED}.
Life Extension Ultra Prostate Formula: current Life Extension product page and Supplement Facts reviewed {CHECKED}.
Prostadine: current branded product page plus a recent ingredient-analysis release reviewed {CHECKED}. Product pages in this market can change; confirm the current bottle label.
ProstaVive: multiple branded/seller pages reviewed {CHECKED}; inconsistent formula descriptions were observed, so we flag the need to verify the exact seller and physical label.
Why source URLs are shown as text, not outbound links
The publisher requested that public outbound links remain focused on the supplied affiliate destination. Source identities are therefore provided for auditability without turning the editorial pages into a directory of external commercial links.
